- FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
- Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
- Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
- Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
- New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
- Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
- Guardant Health to Participate in Upcoming Investor Conferences
- Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
More ▼
Key statistics
On Wednesday, Guardant Health Inc (GH:NSQ) closed at 18.10, 14.48% above the 52 week low of 15.81 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.72 |
---|---|
High | 18.11 |
Low | 17.34 |
Bid | 17.80 |
Offer | 18.30 |
Previous close | 18.10 |
Average volume | 1.78m |
---|---|
Shares outstanding | 121.71m |
Free float | 116.66m |
P/E (TTM) | -- |
Market cap | 2.20bn USD |
EPS (TTM) | -4.28 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 21:00 BST.
More ▼